The suitability of a rolled BHK21 monolayer system for the production of vaccines against the SAT types of foot-and-mouth disease virus. I. Adaptation of virus isolates to the system, immunogen yields achieved and assessment of subtype cross reactivity.

In an examination of 34 southern African SAT-type foot-and-mouth disease viruses, all but 1 attained satisfactory levels of infectivity within 6 passages in rolled BHK21 monolayer cell cultures. However, there were marked differences between adapted viruses with respect to the mass of immunogen (146S material) produced. Several isolates which consistently produced levels greater than or equal to 2 micrograms/ml were identified. In cross neutralization tests using post-vaccinal sera, SAT-1 and SAT-2 isolates showed considerable diversity and none of the viruses tested would be expected to produce a broad-spectrum response if incorporated into a vaccine. On the other hand, when 2 of the SAT-2 isolates were incorporated into the same vaccine a distinctly broader response resulted.

[1]  J. Crowther Antigenic structure of foot and mouth disease virus. , 1986, Revue scientifique et technique.

[2]  G. Thomson,et al.  Foot-and-mouth disease and the African buffalo (Syncerus caffer). II. Virus excretion and transmission during acute infection. , 1986, The Onderstepoort journal of veterinary research.

[3]  G. Thomson,et al.  Buffalo in the northern Natal game parks show no serological evidence of infection with foot-and-mouth disease virus. , 1985, The Onderstepoort journal of veterinary research.

[4]  M. Rweyemamu,et al.  The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle. , 1984, Journal of biological standardization.

[5]  T. Pay Variation in foot and mouth disease : application to vaccination. , 1983, Revue scientifique et technique.

[6]  G. Mowat,et al.  Sources of variations encountered during the selection and production of three strains of FMD virus for the development of vaccine for use in Nigeria. , 1982, Journal of biological standardization.

[7]  M. Dupasquier,et al.  Report on two years experience in foot-and-mout h disease vaccine production at the Botswana Vaccine Institute , 1982 .

[8]  Doel Tr,et al.  Further developments in the quantification of small RNA viruses by U.V. photometry of sucrose density gradients. , 1981 .

[9]  J. Booth,et al.  Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains , 1978, Journal of Hygiene.

[10]  M. Rweyemamu The Selection of Vaccine Strains of Foot and Mouth Disease Virus , 1978 .

[11]  J. G. Bekkum Factors Affecting the Quality of Foot and Mouth Disease Vaccines , 1978 .

[12]  L. Nardelli,et al.  10-years experience with a 28,800 roller bottle plant for FMD vaccine production. , 1976, Developments in biological standardization.

[13]  R. Hedger Foot-and-mouth disease and the African buffalo (Syncerus caffer). , 1972, Journal of comparative pathology.